Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study

Gonzales, Emmanuel; Hardikar, Winita; Stormon, Michael; Baker, Alastair; Hierro, Loreto; Gliwicz, Dorota; Lacaille, Florence; Lachaux, Alain; Sturm, Ekkehard; Setchell, Kenneth D. R.; Kennedy, Ciara; Dorenbaum, Alejandro; Steinmetz, Jana; Desai, Nirav K.; Wardle, Andrew J.; Garner, Will; Vig, Pamela; Jaecklin, Thomas; Sokal, Etienne M.; Jacquemin, Emmanuel

dc.contributor.author	Sturm, Ekkehard
dc.date.accessioned	2022-08-01T14:30:14Z
dc.date.available	2022-08-01T14:30:14Z
dc.date.issued	2021
dc.identifier.issn	0140-6736
dc.identifier.uri	http://hdl.handle.net/10900/129831
dc.language.iso	en	de_DE
dc.publisher	New York	de_DE
dc.relation.uri	https://doi.org/10.1016/S0140-6736(21)01256-3	de_DE
dc.subject.ddc	610	de_DE
dc.title	Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_00792
utue.publikation.seiten	1581-1592	de_DE
utue.personen.roh	Gonzales, Emmanuel
utue.personen.roh	Hardikar, Winita
utue.personen.roh	Stormon, Michael
utue.personen.roh	Baker, Alastair
utue.personen.roh	Hierro, Loreto
utue.personen.roh	Gliwicz, Dorota
utue.personen.roh	Lacaille, Florence
utue.personen.roh	Lachaux, Alain
utue.personen.roh	Sturm, Ekkehard
utue.personen.roh	Setchell, Kenneth D. R.
utue.personen.roh	Kennedy, Ciara
utue.personen.roh	Dorenbaum, Alejandro
utue.personen.roh	Steinmetz, Jana
utue.personen.roh	Desai, Nirav K.
utue.personen.roh	Wardle, Andrew J.
utue.personen.roh	Garner, Will
utue.personen.roh	Vig, Pamela
utue.personen.roh	Jaecklin, Thomas
utue.personen.roh	Sokal, Etienne M.
utue.personen.roh	Jacquemin, Emmanuel
dcterms.isPartOf.ZSTitelID	Lancet	de_DE
dcterms.isPartOf.ZS-Issue	10311	de_DE
dcterms.isPartOf.ZS-Volume	398	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE